1. Stocks
    2. /
  2. Ebos Group Ltd (ASX: EBO)
    3. /

Ebos Group Ltd (ASX: EBO) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Ebos Group Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $6.45 billion
P/E Ratio 23.69
Dividend Yield 2.93%
Shares Outstanding 194.68 million
Earnings per share 1.544
Dividend per share 1.01
Year To Date Return 4.02%
Earnings Yield 4.22%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Ebos Group Ltd (ASX: EBO)
    Latest News

    a woman
    ⏸️ Investing

    What sell off? 24 S&P/ASX 200 shares churn out gains

    | John Hopkins

    24 of the best performing shares on the ASX.

    Read more »

    a woman
    ⏸️ Investing

    Could a bidding war erupt for Greencross Limited?

    | Sean O'Neill

    Private equity firms TPG, Carlyle Group, and KKR are reportedly running the ruler over Greencross Limited (ASX:GXL).

    Read more »

    a woman
    ⏸️ Investing

    Did you catch these major events in the market last week?

    | Sean O'Neill

    A2 MILK FPO NZ (ASX:A2M) upgrades its profit forecast.

    Read more »

    a woman
    ⏸️ Investing

    SOARING: Why the Greencross Limited share price is up 30% this week

    | Ryan Newman (TMFNewmy)

    Greencross Limited (ASX:GXL) shares are in hot demand right now.

    Read more »

    a woman
    ⏸️ Investing

    Is a bidding war about to break out over Greencross Limited?

    | Mike King

    EBOS Group Ltd (ASX:EBO) reported to be joining the race for pet care group Greencross Limited (ASX:GXL)

    Read more »

    ⏸️ Investing

    Woolworths Limited, Coca-Cola Amatil Ltd and EBOS Group Ltd: Should you buy?

    | Owen Raszkiewicz

    Retailers are easy to understand businesses which can offer big dividends. Woolworths Limited (ASX:WOW), Coca-Cola Amatil Ltd (ASX:CCL) and EBOS…

    Read more »

    a woman
    ⏸️ Investing

    4 winners and 4 losers of reporting season

    | Regan Pearson

    Which companies have shone and which have stumbled this reporting season?

    Read more »

    a woman
    ⏸️ Investing

    3 healthcare companies with rocketing long-term growth

    | Regan Pearson

    Three healthcare companies with attractive long-term growth prospects.

    Read more »

    Frequently Asked Questions

    Yes, EBOS Group has historically paid two partially franked shareholder dividends a year.

    EBOS Group generally pays its shareholder dividends in March and September. 

    Yes, EBOS has a dividend reinvestment plan to allow shareholders to reinvest all or part of their dividends.

    EBOS Group Ltd listed on the ASX on 6 September 2013.

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    29 Aug 2024 $0.5043 0.00% Final 18 Sep 2024
    29 Feb 2024 $0.1510 0.00% Supplemental 22 Mar 2024
    07 Sep 2023 $0.0251 0.00% Supplemental 29 Sep 2023
    07 Sep 2023 $0.4705 0.00% Final 29 Sep 2023
    02 Mar 2023 $0.0234 0.00% Supplemental 17 Mar 2023
    02 Mar 2023 $0.4259 0.00% Interim 17 Mar 2023
    08 Sep 2022 $0.0216 0.00% Supplemental 30 Sep 2022
    08 Sep 2022 $0.3800 0.00% Final 30 Sep 2022
    03 Mar 2022 $0.0207 0.00% Supplemental 18 Mar 2022
    03 Mar 2022 $0.3917 0.00% Interim 18 Mar 2022
    09 Sep 2021 $0.0203 0.00% Supplemental 24 Sep 2021
    09 Sep 2021 $0.3953 0.00% Final 24 Sep 2021
    04 Mar 2021 $0.0188 0.00% Supplemental 18 Mar 2021
    04 Mar 2021 $0.3506 0.00% Interim 18 Mar 2021
    24 Sep 2020 $0.0176 0.00% Supplemental 09 Oct 2020
    24 Sep 2020 $0.3289 0.00% Final 09 Oct 2020
    12 Mar 2020 $0.0165 0.00% Supplemental 03 Apr 2020
    12 Mar 2020 $0.3232 0.00% Interim 03 Apr 2020
    26 Sep 2019 $0.0163 0.00% Supplemental 11 Oct 2019
    26 Sep 2019 $0.3076 0.00% Final 11 Oct 2019
    14 Mar 2019 $0.0152 0.00% Supplemental 05 Apr 2019
    14 Mar 2019 $0.2920 0.00% Interim 05 Apr 2019
    27 Sep 2018 $0.2871 0.00% Final 12 Oct 2018
    15 Mar 2018 $0.0146 0.00% Supplemental 06 Apr 2018
    15 Mar 2018 $0.2766 0.00% Interim 06 Apr 2018
    28 Sep 2017 $0.0146 0.00% Supplemental 13 Oct 2017
    28 Sep 2017 $0.2664 0.00% Final 13 Oct 2017
    16 Mar 2017 $0.2453 0.00% Interim 07 Apr 2017
    29 Sep 2016 $0.2697 0.00% Final 14 Oct 2016
    10 Mar 2016 $0.2075 0.00% Interim 01 Apr 2016
    30 Sep 2015 $0.2024 0.00% Final 16 Oct 2015
    11 Mar 2015 $0.1884 0.00% Interim 02 Apr 2015
    01 Oct 2014 $0.1650 0.00% Final 17 Oct 2014
    12 Mar 2014 $0.1776 0.00% Interim 04 Apr 2014
    06 Apr 2011 $0.1350 0.00% Interim 21 Apr 2011
    08 Sep 2010 $0.1750 0.00% Final 08 Oct 2010
    15 Mar 2010 $0.1350 0.00% Interim 13 Apr 2010
    07 Sep 2009 $0.1450 0.00% Final 02 Oct 2009
    23 Mar 2009 $0.1050 0.00% Interim 21 Apr 2009
    15 Sep 2008 $0.0238 0.00% Supplemental 10 Oct 2008
    15 Sep 2008 $0.1350 0.00% Final 10 Oct 2008
    14 Apr 2008 $0.0168 0.00% Supplemental 09 May 2008
    14 Apr 2008 $0.0950 0.00% Interim 09 May 2008
    23 Oct 2007 $0.0229 0.00% Supplemental 26 Oct 2007
    23 Oct 2007 $0.1300 0.00% Final 26 Oct 2007
    16 Apr 2007 $0.0168 0.00% Supplemental 20 Apr 2007
    16 Apr 2007 $0.0950 0.00% Interim 20 Apr 2007
    24 Oct 2006 $0.0229 0.00% Supplemental 27 Oct 2006
    24 Oct 2006 $0.1300 0.00% Final 27 Oct 2006
    03 Apr 2006 $0.0168 0.00% Supplemental 07 Apr 2006
    03 Apr 2006 $0.0950 0.00% Interim 07 Apr 2006
    03 Oct 2005 $0.0221 0.00% Supplemental 07 Oct 2005
    03 Oct 2005 $0.1250 0.00% Final 07 Oct 2005
    14 Mar 2005 $0.0159 0.00% Supplemental 18 Mar 2005
    14 Mar 2005 $0.0900 0.00% Interim 18 Mar 2005

    EBO ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Ebos Group Ltd

    EBOS Group Ltd (ASX: EBO) is the largest pharmaceutical wholesaler and distributor across Australia, New Zealand, and Southeast Asia. The company provides pharmaceutical and wellness products to community pharmacies, public and private hospitals, day surgeries, general practices, aged care facilities, and specialist clinics.

    EBOS Group also operates an animal health product wholesale, manufacturing, and retail business, as well as providing third-party logistics services.

    The vast majority of the company's revenue derives from its services to community pharmacies and institutional healthcare providers, which accounts for about 80% of revenue. Its Australian operations similarly contribute around 80% of its total revenue.

     

    EBO Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    20 Dec 2024 $33.14 $-0.08 -0.24% 250,058 $33.23 $33.33 $32.89
    19 Dec 2024 $33.22 $0.08 0.24% 79,015 $34.19 $34.19 $32.69
    18 Dec 2024 $33.14 $-0.41 -1.22% 69,641 $33.20 $33.28 $32.73
    17 Dec 2024 $33.55 $-0.02 -0.06% 20,508 $33.54 $33.60 $33.05
    16 Dec 2024 $33.57 $0.20 0.60% 16,849 $33.30 $33.59 $32.99
    13 Dec 2024 $33.37 $0.12 0.36% 30,584 $33.29 $33.59 $33.14
    12 Dec 2024 $33.25 $-0.15 -0.45% 19,448 $33.32 $33.36 $32.87
    11 Dec 2024 $33.40 $0.13 0.39% 23,556 $33.46 $33.50 $33.19
    10 Dec 2024 $33.27 $-0.25 -0.75% 12,971 $33.58 $33.66 $33.27
    09 Dec 2024 $33.52 $-0.47 -1.38% 44,452 $33.89 $33.93 $33.49
    06 Dec 2024 $33.99 $-0.21 -0.61% 20,117 $34.20 $34.26 $33.76
    05 Dec 2024 $34.20 $-0.28 -0.81% 10,853 $34.50 $34.62 $34.05
    04 Dec 2024 $34.48 $-0.39 -1.12% 12,709 $34.86 $34.86 $34.43
    03 Dec 2024 $34.87 $0.07 0.20% 36,395 $34.84 $34.98 $34.47
    02 Dec 2024 $34.80 $0.15 0.43% 19,532 $34.57 $35.06 $34.51
    29 Nov 2024 $34.65 $-0.13 -0.37% 17,753 $34.13 $34.79 $34.13
    28 Nov 2024 $34.78 $0.23 0.67% 15,179 $34.71 $34.86 $34.54
    27 Nov 2024 $34.55 $0.27 0.79% 42,712 $34.52 $34.89 $34.10
    26 Nov 2024 $34.28 $-0.30 -0.87% 40,377 $34.58 $34.58 $33.86
    25 Nov 2024 $34.58 $0.83 2.46% 80,920 $33.69 $34.58 $33.33
    22 Nov 2024 $33.75 $-0.08 -0.24% 24,457 $33.79 $34.16 $33.60
    21 Nov 2024 $33.83 $-0.07 -0.21% 43,840 $33.52 $34.00 $33.41

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    18 Sep 2024 Stuart McLauchlan Issued 43 $1,482
    Dividend Reinvestment Plan (DRP). NZ$
    22 Mar 2024 Stuart McLauchlan Issued 39 $1,390
    Dividend Reinvestment Plan (DRP). NZ$

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Ms Elizabeth(Liz) Mary Coutts Non-Executive DirectorNon-Executive Chairman Nov 2013
    Ms Coutts is member of the Risk Committee. She is Chair of Oceania Healthcare Limited and 2degrees Group Limited, Director of EBOS Group subsidiaries in New Zealand and Member, Marsh New Zealand Advisory Board.
    Mr Mark Alan Bloom Non-Executive Director Sep 2022
    Mr Bloom is a member of the Risk Committee. He is a former director of Pacific Smiles Group Limited and Abacus Property Group. Mark has also held several senior finance roles, including being CFO and executive director for insurance and financial services companies Liberty Life, South Africa and Manulife Financial, Canada.
    Mr Stuart McLauchlan Non-Executive Director Jul 2019
    Mr McLauchlan is Chairman of the Risk Committee. He is also a governor of the New Zealand Sports Hall of Fame and a member of the Marsh New Zealand Advisory Board. He was formerly a director of Ngai Tahu Tourism Ltd.
    Dr Tracey Leigh Batten Non-Executive Director Jul 2021
    Dr Batten is currently Chair of the Accident Compensation Corporation and a non-executive director of Medibank Private Limited and Nanosonics Limited. She was previously a non-executive director of National Institute of Water and Atmospheric Research, Abano Healthcare Group Limited and various other healthcare related research institutes, charities and industry and government bodies. During her executive career she was Group CEO of Imperial College Healthcare NHS Trust in the United Kingdom, Group CEO of St Vincent's Health Australia, CEO of Eastern Health and CEO of Dental Health Services Victoria.
    Ms Julie Tay Non-Executive Director May 2023
    Ms Tay is currently a director of Sonova, a global hearing care solutions company, headquartered in Switzerland and listed on the Swiss stock exchange. She has over 30 years of experience in international executive and non-executive roles across consumer healthcare, medical devices, and digital healthcare. Julie was Senior Vice President and Managing Director, Asia Pacific, and member of the global Executive Management Committee for Align Technology. Prior to this time, she was regional head of Bayer Healthcare (Diabetes Care) in Asia Pacific and previously held senior executive roles in Asia at Johnson Diversey and Johnson & Johnson.
    Mr Andrew McLean Chief Executive Officer Aug 2024
    -
    Mr John Cullity Chief Executive Officer Jul 2014
    -
    Julie Dillon CEO Animal Care
    -
    Matt Muscio CEO Medical Technology
    -
    Brett Barons CEO Symbion
    -
    Andrew McLean Chief Executive Officer
    -
    John Cullity Chief Executive Officer
    -
    Leonard Hansen Chief Financial Officer
    -
    Mithran Naiker Chief Information Officer
    -
    David Lewis EGM
    -
    Simon Bunde EGM Strategic Operations ESG and Innovation
    -
    Martin Krauskopf EGM Strategy and Mergers and Acquisitions
    -
    Janelle Cain General Counsel
    -
    Jacinta McCarthy Group GM Human Resources
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Sybos Holdings Pte Limited 36,698,002 18.99%
    Custodial Services Limited 12,863,254 6.66%
    HSBC Nominees (New Zealand) Limited NZCSD 11,945,394 6.18%
    JP Morgan Chase Bank NA NZ Branch-Segregated Clients Acct NZCSD 10,313,439 5.34%
    BNP Paribas Nominees (NZ) Limited NZCSD 10,162,902 5.26%
    HSBC Nominees (New Zealand) Limited A/C State Street NZCSD 10,031,609 5.19%
    JP Morgan Nominees Australia Limited 9,884,811 5.12%
    Tea Custodians Limited Client Property Trust Account NZCSD 7,607,290 3.94%
    Forsyth Barr Custodians Limited 6,814,524 3.53%
    Accident Compensation Corporation NZCSD 5,567,722 2.88%
    Citibank Nominees (New Zealand) Limited NZCSD 5,393,354 2.79%
    FNZ Custodians Limited 4,771,289 2.47%
    HSBC Nominees A/C NZ Superannuation Fund Nominees Limited NZCSD 4,218,386 2.18%
    HSBC Custody Nominees (Australia) Limited 3,881,197 2.01%
    JBWere (NZ) Nominees Limited 2,556,423 1.32%
    ANZ Wholesale Australasian Share Fund NZCSD 2,504,047 1.29%
    New Zealand Depository Nominee Limited 2,385,485 1.23%
    Whyte Adder No 3 Limited 1,797,874 0.93%
    Generate Kiwisaver Public Trust nominees Limited <NZCSD> 1,642,442 0.85%
    Simplicity Nominees Limited NZCSD 1,566,940 0.81%

    Profile

    since

    Note